Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy

References

• Schulte H. D., Borisov K., Gams E., Gramsch‐Zabel H., Losse B., Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy—long term results after surgical theraphy. Thorac Cardiovasc Surg 1999; 47: 213–28
   PubMed Web of Science ®Google Scholar
• Merrill W. H., Friesinger G. C., Graham T. P Jr. Long‐lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2000; 69: 1732–35
   PubMed Web of Science ®Google Scholar
• van der Lee C., Kofflard M. J., van Herwerden L. A., Vletter W. B., ten Cate F. J. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation 2003; 108: 2088–2092
   PubMedGoogle Scholar
• Nishimura R. A., Trusty J. M., Hayes D. L. Dual‐chamber pacing for hypertrophic cardiomyopathy: a randomized, double‐blind, crossover trial. J Am Coll Cardiol 1997; 29: 435–41
   PubMed Web of Science ®Google Scholar
• Maron B. J., Nishimura R. A., McKenna W. J., Rakowski H., Josephson M. E., Kieval R. S. Assessment of permanent dual‐chamber pacing as a treatment for drug‐refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double‐blind, cross‐over study (M‐PATHY). Circulation 1999; 99: 2927–33
   PubMed Web of Science ®Google Scholar
• Kappemberg L. J., Linde C., Jeanrenaud X. Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. Europace 1999; 1: 77–84
   PubMed Web of Science ®Google Scholar
• Faber L., Meissner A., Ziemssen P., Seggewiss H. Percutaneuos transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Long term follow up of the first series of 25 patients. Heart 2000; 83: 326–31
   PubMed Web of Science ®Google Scholar
• Lakkis N. M., Nagueh S. F., Dunn J. K., Killip D., Spencer W. H III. Non surgical septal reduction therapy for hypertrophic obstructive cardiomyopahty. One‐year follow‐up. J Am Coll Cardiol 2000; 36: 852–55
   PubMed Web of Science ®Google Scholar
• Lakkis N. M., Nagueh S. F., Kleiman N. S. Echocardiogrphy‐guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998; 17: 1750–55
   Google Scholar
• Nagueh S. F., Lakkis N. M., He Z. X. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998; 32: 225–29
   PubMed Web of Science ®Google Scholar
• Faber L., Seggewiss H., Gleichmann U. Percutaneuos transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998; 98: 2415–21
   PubMed Web of Science ®Google Scholar
• Faber L., Ziemssen P., Seggewiss H. Targeting percutaneuos transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr 2000; 13: 1074–79
   PubMed Web of Science ®Google Scholar
• Reinhard W., ten Cate F. J., Scholten M., De Laat L. E., Vos J. Permanent pacing for complete atrioventricular block after nonsurgical (alchool) septal reduction in patients with hypertrophic cardiomyopathy. Am J Cardiol 2004; 93: 1064–66
   PubMed Web of Science ®Google Scholar
• Flores‐Ramirez R., Lakkis N. M., Middleton K. J., Killip D., Spencer W. H 3rd., Nagueh S. F. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001; 37: 208–14
   PubMed Web of Science ®Google Scholar
• Henein M. Y., O'Sullivan C. A., Ramzy I. S., Sigwart U., Gibson D. G. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999; 34: 1117–22
   PubMed Web of Science ®Google Scholar
• Chang S. M., Nagueh S. F., Spencer W. H 3rd., Lakkis N. M. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003; 42: 296–300
   PubMed Web of Science ®Google Scholar
• Mullen M. J., Dias B. F., Walker F., Siu S. C., Benson L. N., McLaughlin P. R. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol 2003; 41: 285–92
   PubMed Web of Science ®Google Scholar
• Bertel T., Konorza T., Arjumand J. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 2003; 18: 795–97
   Google Scholar
• Szili‐Torok T., Kimman G. P., Theuns D., Res J., Roelandt J. R., Jordaens L. J. Visualization of intra‐cardiac structures and radiofrequency lesions using intracardiac echocardiography. Eur J Echoacardiogr 2003; 4: 17–22
   PubMedGoogle Scholar
• Marrouche N. F., Martin D. O., Wazni O. A. Phased–array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 197: 2710–16
   Google Scholar